Betancourt-Cuellar SL, Benveniste M, Palacio DP, et al. Esophageal cancer: Tumor-Node-Metastasis Staging[J]. Radiol Clin North Am. 2021;59(2):219–29.

Article  PubMed  Google Scholar 

Yang H, Wang F, Hallemeier CL, et al. Oesophageal cancer[J]. Lancet. 2024;404(10466):1991–2005.

Article  PubMed  Google Scholar 

Deboever N, Jones CM, Yamashita K, et al. Advances in diagnosis and management of cancer of the esophagus[J]. BMJ. 2024;385:e74962.

Article  Google Scholar 

Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2024;74(3):229–63.

PubMed  Google Scholar 

Global incidence. prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021[J]. Lancet. 2024;403(10440):2133–61.

Article  Google Scholar 

Uhlenhopp DJ, Then EO, Sunkara T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors[J]. Clin J Gastroenterol. 2020;13(6):1010–21.

Article  PubMed  Google Scholar 

Baiu I, Backhus L. Esophageal Cancer Surgery[J]. JAMA. 2020;324(15):1580.

Article  PubMed  Google Scholar 

Eisner DC. Esophageal cancer: treatment advances and need for screening[J]. JAAPA. 2024;37(4):19–24.

Article  PubMed  Google Scholar 

Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer[J]. Curr Oncol Rep. 2022;24(3):375–85.

Article  CAS  PubMed  Google Scholar 

Codipilly DC, Wang KK. Squamous cell carcinoma of the esophagus[J]. Gastroenterol Clin North Am. 2022;51(3):457–84.

Article  PubMed  Google Scholar 

Shen L, Kato K, Kim SB, et al. Tislelizumab versus chemotherapy as Second-Line treatment for advanced or metastatic esophageal squamous cell carcinoma (RATIONALE-302): A randomized phase III Study[J]. J Clin Oncol. 2022;40(26):3065–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee A, Keam SJ. Tislelizumab: first approval[J]. Drugs. 2020;80(6):617–24.

Article  CAS  PubMed  Google Scholar 

Qiu MZ, Oh DY, Kato K, et al. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial[J]. BMJ. 2024;385:e78876.

Article  Google Scholar 

Parvathaneni V, Kulkarni NS, Muth A, et al. Drug repurposing: a promising tool to accelerate the drug discovery process[J]. Drug Discov Today. 2019;24(10):2076–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roy S, Dhaneshwar S, Bhasin B. Drug repurposing: an emerging tool for drug reuse, recycling and discovery[J]. Curr Drug Res Rev. 2021;13(2):101–19.

Article  PubMed  Google Scholar 

Tan G, Sloan EK, Lambert P, et al. Drug repurposing using real-world data[J]. Drug Discov Today. 2023;28(1):103422.

Article  CAS  PubMed  Google Scholar 

Xia Y, Sun M, Huang H, et al. Drug repurposing for cancer therapy[J]. Signal Transduct Target Ther. 2024;9(1):92.

Article  PubMed  PubMed Central  Google Scholar 

Singhal S, Maheshwari P, Krishnamurthy PT, et al. Drug repurposing strategies for Non-cancer to cancer Therapeutics[J]. Anticancer Agents Med Chem. 2022;22(15):2726–56.

Article  CAS  PubMed  Google Scholar 

Maldonado R, Drago F. Editorial: drug repurposing for COVID-19 therapy[J]. Front Pharmacol. 2021;12:748886.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Israr J, Alam S, Kumar A. Drug repurposing for respiratory infections[J]. Prog Mol Biol Transl Sci. 2024;207:207–30.

Article  CAS  PubMed  Google Scholar 

Kato Y, Nishiyama K, Nishimura A, et al. Drug repurposing for the treatment of COVID-19[J]. J Pharmacol Sci. 2022;149(3):108–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciliberto G, Mancini R, Paggi MG. Drug repurposing against COVID-19: focus on anticancer agents[J]. J Exp Clin Cancer Res. 2020;39(1):86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stokes M, Patel P, Abdijadid S. Disulfiram[J]. 2025.

Zhong S, Shengyu L, Xin S, et al. Disulfiram in glioma: literature review of drug repurposing[J]. Front Pharmacol. 2022;13:933655.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng M, Wu B, Wei W, et al. Disulfiram: A novel repurposed drug for cancer therapy[J]. Chin Med J (Engl). 2024;137(12):1389–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weyerhauser P, Kantelhardt SR, Kim EL. Re-purposing chloroquine for glioblastoma: potential merits and confounding variables[J]. Front Oncol. 2018;8:335.

Article  PubMed  PubMed Central  Google Scholar 

Cai Y, Cai J, Ma Q, et al. Chloroquine affects autophagy to achieve an anticancer effect in EC109 esophageal carcinoma cells in vitro[J]. Oncol Lett. 2018;15(1):1143–8.

PubMed  Google Scholar 

Harada K, Rogers JE, Iwatsuki M, et al. Recent advances in treating oesophageal cancer. F1000Res. 2020. https://doi.org/10.12688/f1000research.22926.1.

Article  PubMed  PubMed Central  Google Scholar 

Bohme F, Racz K, Sebesta CJ, et al. [Esophageal Cancer][J]. Wien Med Wochenschr. 2023;173(9–10):209–15.

PubMed  Google Scholar 

Extermann M, Al-Jumayli M, Sam C, et al. Oncogeriatric developments[J]. Gerontology. 2023;69(9):1045–55.

Article  PubMed  Google Scholar 

Hassan C, Antonelli G, Chiu PW, et al. Position statement of the world endoscopy organization: role of endoscopy in screening, diagnosis, and treatment of esophageal superficial squamous neoplasia[J]. Dig Endosc; 2024.

Wei MT, Friedland S. Early esophageal cancer: what the gastroenterologist needs to know[J]. Gastroenterol Clin North Am. 2021;50(4):791–808.

Article  PubMed  Google Scholar 

Xia R, Zeng H, Liu W, et al. Estimated cost-effectiveness of endoscopic screening for upper gastrointestinal tract cancer in high-risk areas in China[J]. JAMA Netw Open. 2021;4(8):e2121403.

Article  PubMed  PubMed Central  Google Scholar 

Ji Y, Du X, Zhu W, et al. Efficacy of concurrent chemoradiotherapy with S-1 vs radiotherapy alone for older patients with esophageal cancer: A multicenter randomized phase 3 clinical Trial[J]. JAMA Oncol. 2021;7(10):1459–66.

Article  PubMed  PubMed Central  Google Scholar 

Eads JR, Haller DG. Primary chemoradiotherapy for older patients with esophageal cancer[J]. JAMA Oncol. 2021;7(10):1451–2.

Article  PubMed  Google Scholar 

Kakeji Y, Oshikiri T, Takiguchi G, et al. Multimodality approaches to control esophageal cancer: development of chemoradiotherapy, chemotherapy, and immunotherapy[J]. Esophagus. 2021;18(1):25–32.

Article  PubMed